Epidemiology, Mechanisms, and Management of Diabetic Gastroparesis
Clinical Gastroenterology and Hepatology , 01/06/2011
Clinical Article
Camilleri M et al. – New therapeutic strategies for gastroparesis include drugs that target the underlying defects, prokinetic agents such as 5–hydroxytryptamine agonists that do not appear to have cardiac or vascular effects, ghrelin agonists, approaches to pace the stomach, and stem cell therapies.
